Drug intelligence / Profile preview

Eldervit

Development stage
Unknown
Lead developer
Elder Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Eldervit is an India‑marketed multivitamin and mineral combination product from Elder Pharmaceuticals that is positioned as a prescription nutraceutical to treat and prevent nutritional deficiencies, anemia, and vitamin B‑complex and vitamin C deficiency states, and to support energy, red blood cell production, and nervous system function.[1][2][3][4][5][7][8][9][11][12][15][18] Formulations (capsules, injections, drops, syrups, gel capsules, sachets, and variants such as Eldervit 12 Combipack and Eldervit Red/ZC) commonly contain methylcobalamin (vitamin B12), folic acid, niacinamide, vitamin C (ascorbic acid), and sometimes vitamin B6 and other B‑complex components; these act as cofactors in one‑carbon transfer reactions, DNA synthesis, erythropoiesis, and energy metabolism and provide antioxidant effects, thereby correcting underlying vitamin deficiencies rather than acting on a single pharmacologic receptor target.[1][3][5][7][9][11][12][15][17][18] Clinically it is used in conditions such as anemia (including B12/folate‑related anemia), general nutritional deficiency, neuropathies related to B12 deficiency, and nonspecific fatigue, and is generally well tolerated with possible gastrointestinal or injection‑site reactions.[1][3][5][7][8][9][11][12][17]

Brand names
EldervitEldervit 12 CombipackEldervit12 CombipackEldervit-12 CombipackEldervit 12 InjectionEldervit12 InjectionEldervit-12 InjectionEldervit CapEldervit RedEldervit ZC

Beyond the preview

Go deeper on Eldervit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eldervit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call